微创医学

目的探讨依达拉奉对颅内支架植入术患者神经功能的影响。方法选择颅内支架植入术后使用依达拉奉治疗的脑血管疾病患者32例为观察组，另选择同期未使用依达拉奉治疗且一般资料与观察组相匹配的脑血管疾病患者35例为对照组。比较两组患者术后颅内血管扩张程度、神经功能及并发症情况。结果两组患者颅内支架植入术后脑血管狭窄均得到明显的扩张，两组比较，差异无统计学意义（P＞0.05）。两组患者术后1天NIHSS评分无显著差异，但术后1周、2周2组NIHSS评分比较，差异有统计学意义（P＜0.05）。结论颅内支架植入术可以显著扩张脑血管狭窄，使用依达拉奉能够明显改善患者神经功能，促进患者早日康复。

ObjectiveTo explore the influence of edaravone on neurologic function of patients after intracranial stent implantation. MethodsThirty two patients with cerebrovascular disease received Edaravone treatment after intracranial stent implantation were chose as observation group; 35 patients with cerebrovascular disease received intracranial stent implantation but did not received Edaravone treatment were chose as control group. The dilatation of intracranial vessel, neurologic function and complications were compared between the two groups. ResultsThe intracranial vessel of two groups were dilated after intracranial stent implantation, but there were not significant difference between two groups (P＜0.05). The NIHSS score did not show significant difference at the first day of post-treatment, but at the first week and second week the NIHSS score showed significant difference (P＜0.05). ConclusionsIntracranial stent implantation could significantly dilated intracranial vessel, and Edaravone can alleviate the neurologic function of patients with cerebrovascular disease.

ref